%0 Journal Article %T Identification of a novel therapeutic target in driver-negative nonsmall cell lung cancer %A Saito, Motonobu %A Kono, Koji %A Kohno, Takashi %J Translational Lung Cancer Research %D 2018 %B 2018 %9 %! Identification of a novel therapeutic target in driver-negative nonsmall cell lung cancer %K %X Molecular targeted therapy against driver gene aberrations has a significantly high positive response rate compared with traditional cytotoxic chemotherapies, and has thus dramatically changed the treatment strategies for malignant tumors, including non-small cell lung cancer (NSCLC) (1). Lung adenocarcinoma (LADC) can be treated with targeted therapy against driver gene aberrations using tyrosine kinase inhibitors (TKIs). %U https://tlcr.amegroups.org/article/view/23560 %P S218-S220 %@ 2226-4477